[x0x0]

Why do you think a lack of ability to detect/quantify these micro-structural abnormalities is hindering clinical trials? Is it a problem of detection lag?

How will your tech enable a disease-modifying treatment? Is the hypothesis your tech is the first way we can even measure?

Are you using standard MRIs and just a layer of software, or do you require some sort of special physical device?

This is all curiosity btw; I love the idea. I used to work on software for confocal microscopy and protein melting curves (to be clear, two different labs) before selling out and working on ads.